Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Chk
    (12)
  • Apoptosis
    (4)
  • CDK
    (2)
  • FLT
    (2)
  • Src
    (2)
  • Aurora Kinase
    (1)
  • Autophagy
    (1)
  • FGFR
    (1)
  • GSK-3
    (1)
  • IFNAR
    (1)
Filter
Search Result
Results for "

checkpoint kinase (chk)

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    12
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
  • Antibody Products
    1
    TargetMol | Antibody_Products
Monalizumab
T766911228763-95-8
Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-γ production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC).
  • $438
In Stock
Size
QTY
TargetMol | Inhibitor Hot